- Home
- HIX vs CLPT Comparison
HIX vs CLPT Comparison
Compare HIX & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HIX | CLPT |
|---|---|---|
| Founded | 1998 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 376.5M | 353.5M |
| IPO Year | 1998 | 2009 |
Fundamental Metrics
Financial Performance| Metric | HIX | CLPT |
|---|---|---|
| Price | $3.95 | $11.72 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 391.7K | ★ 497.4K |
| Earning Date | 01-01-0001 | 05-13-2026 |
| Dividend Yield | ★ 13.14% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $36,971,000.00 |
| Revenue This Year | N/A | $45.67 |
| Revenue Next Year | N/A | $19.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 17.78 |
| 52 Week Low | $3.75 | $8.27 |
| 52 Week High | $4.39 | $30.10 |
Technical Indicators
Market Signals| Indicator | HIX | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 46.45 | 52.71 |
| Support Level | $3.90 | $10.09 |
| Resistance Level | $4.32 | $11.73 |
| Average True Range (ATR) | 0.05 | 0.98 |
| MACD | -0.00 | -0.10 |
| Stochastic Oscillator | 45.83 | 31.33 |
Price Performance
Historical ComparisonAbout HIX Western Asset High Income Fund II Inc.
Western Asset High Income Fund II Inc is a diversified closed-end management investment company. Its investment objective is to maximize current income by investing at least 80% of its net assets and borrowings for investment purposes in high-yield debt securities.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.